Skip to main content
Journal cover image

Prostate biopsy in selecting candidates for hemiablative focal therapy.

Publication ,  Journal Article
Tsivian, M; Hruza, M; Mouraviev, V; Rassweiler, J; Polascik, TJ
Published in: J Endourol
May 2010

Focal therapy (FT) for the management of clinically localized prostate cancer (PCa) is growing from a concept to reality because of increased interest of both patients and physicians. Selection protocols, however, are yet to be established. We discuss the role of prostate biopsy in candidate selection for FT and highlight the different strategies and technical aspects of the use of prostate biopsy in this setting. In our opinion, prostate biopsy plays a major role in the selection process and tailoring appropriate treatment strategy to the patient. FT necessitates dedicated biopsy schemes that would reliably predict the extent, nature, and location of PCa in selected patients. Currently, there is insufficient scientific evidence to propose a specific biopsy scheme that could fit every candidate, providing accurate characterization of the disease in the individual patient. Further research is necessary to establish solid selection protocols that would reliably identify appropriate candidates for FT of PCa.

Duke Scholars

Published In

J Endourol

DOI

EISSN

1557-900X

Publication Date

May 2010

Volume

24

Issue

5

Start / End Page

849 / 853

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Prostatic Neoplasms
  • Prostate
  • Patient Selection
  • Neoplasm Staging
  • Male
  • Humans
  • Biopsy
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tsivian, M., Hruza, M., Mouraviev, V., Rassweiler, J., & Polascik, T. J. (2010). Prostate biopsy in selecting candidates for hemiablative focal therapy. J Endourol, 24(5), 849–853. https://doi.org/10.1089/end.2009.0473
Tsivian, Matvey, Marcel Hruza, Vladimir Mouraviev, Jens Rassweiler, and Thomas J. Polascik. “Prostate biopsy in selecting candidates for hemiablative focal therapy.J Endourol 24, no. 5 (May 2010): 849–53. https://doi.org/10.1089/end.2009.0473.
Tsivian M, Hruza M, Mouraviev V, Rassweiler J, Polascik TJ. Prostate biopsy in selecting candidates for hemiablative focal therapy. J Endourol. 2010 May;24(5):849–53.
Tsivian, Matvey, et al. “Prostate biopsy in selecting candidates for hemiablative focal therapy.J Endourol, vol. 24, no. 5, May 2010, pp. 849–53. Pubmed, doi:10.1089/end.2009.0473.
Tsivian M, Hruza M, Mouraviev V, Rassweiler J, Polascik TJ. Prostate biopsy in selecting candidates for hemiablative focal therapy. J Endourol. 2010 May;24(5):849–853.
Journal cover image

Published In

J Endourol

DOI

EISSN

1557-900X

Publication Date

May 2010

Volume

24

Issue

5

Start / End Page

849 / 853

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Prostatic Neoplasms
  • Prostate
  • Patient Selection
  • Neoplasm Staging
  • Male
  • Humans
  • Biopsy
  • 3202 Clinical sciences
  • 1103 Clinical Sciences